McKesson Corporation (MCK) is gathering an increasing amount of investor attention, with its compelling growth and reasonable price. Various corporate entities have been investing heavily in the firm, with many boosting their stake like Aquatic Capital Management, Holocene Advisors and Orion Porfolio Solutions. There has been a considerable reshuffling of holdings by others, whereas some institutions, such as Park National Corp OH and the Swiss National Bank, have reduced their positions. MCK shares have been subjected to variable trading volumes and fluctuations in price, with some pullbacks noted. However, Barclay's expects the price to remain favorable and has raised its target. The corporation's Q3 earnings were strong but with limited upside. McKesson's legal chief sold 2,725 shares, while Bank of America sees upside in McKesson's biosimilar push, raising the target to $1,040. The firm has announced the Q4 fiscal 2026 earnings release date and CFO transition plans. Institutional ownership of McKesson is significant, with 86% held by such entities. Despite plans for a spin-off, Deutsche Bank has raised their target for McKesson. The firm recently completed the divestiture of its Norwegian operations.
Mckesson Corporation MCK News Analytics from Mon, 17 Nov 2025 08:00:00 GMT to Sat, 21 Mar 2026 11:09:01 GMT -
Rating 7
- Innovation -3
- Information 8
- Rumor 2
